PH20198A - Antibiotic a51568 factor a and b,their method of preparation and pharmaceutical composition - Google Patents

Antibiotic a51568 factor a and b,their method of preparation and pharmaceutical composition

Info

Publication number
PH20198A
PH20198A PH29980A PH29980A PH20198A PH 20198 A PH20198 A PH 20198A PH 29980 A PH29980 A PH 29980A PH 29980 A PH29980 A PH 29980A PH 20198 A PH20198 A PH 20198A
Authority
PH
Philippines
Prior art keywords
antibiotic
factor
preparation
pharmaceutical composition
formula
Prior art date
Application number
PH29980A
Other languages
English (en)
Inventor
Marvin Martin Hoehn
Gary G Marconi
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH20198A publication Critical patent/PH20198A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365Nocardia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH29980A 1982-12-20 1983-12-15 Antibiotic a51568 factor a and b,their method of preparation and pharmaceutical composition PH20198A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45088082A 1982-12-20 1982-12-20

Publications (1)

Publication Number Publication Date
PH20198A true PH20198A (en) 1986-10-16

Family

ID=23789893

Family Applications (1)

Application Number Title Priority Date Filing Date
PH29980A PH20198A (en) 1982-12-20 1983-12-15 Antibiotic a51568 factor a and b,their method of preparation and pharmaceutical composition

Country Status (24)

Country Link
EP (1) EP0112184B1 (es)
JP (2) JPS59118798A (es)
KR (1) KR860001497B1 (es)
AT (1) ATE42571T1 (es)
AU (1) AU563466B2 (es)
CA (1) CA1214413A (es)
DD (1) DD210709A1 (es)
DE (1) DE3379735D1 (es)
DK (1) DK167688B1 (es)
EG (1) EG16163A (es)
ES (1) ES8504935A1 (es)
FI (1) FI834594A (es)
GB (1) GB2132207B (es)
GR (1) GR78784B (es)
HK (1) HK72088A (es)
HU (1) HU192971B (es)
IE (1) IE56382B1 (es)
IL (1) IL70441A (es)
NZ (1) NZ206592A (es)
PH (1) PH20198A (es)
PT (1) PT77810A (es)
RO (1) RO87735A2 (es)
SU (1) SU1194285A3 (es)
ZA (1) ZA839269B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3572178D1 (en) * 1984-04-16 1989-09-14 Lilly Co Eli Improvements in and relating to antibiotics m43a, m43b, m43c and m43d
IL78597A0 (en) * 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
JP2577133B2 (ja) * 1989-11-27 1997-01-29 スティフティング フォール ド テフニスヘ ウェッテンスハッペン 船舶のプロペラ
RU2633511C1 (ru) * 2016-06-29 2017-10-12 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Штамм Amycolatopsis orientalis - продуцент антибиотика диметилванкомицина и способ получения антибиотика

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322406A (en) * 1980-12-18 1982-03-30 Eli Lilly And Company Antibiotic A-4696 factors B1, B2, B3, C1a, C3 and E1
US4322343A (en) * 1980-12-18 1982-03-30 Eli Lilly And Company Pseudo-aglycone of actaplanin

Also Published As

Publication number Publication date
GB2132207B (en) 1986-06-04
ATE42571T1 (de) 1989-05-15
DK167688B1 (da) 1993-12-06
HK72088A (en) 1988-09-16
JPH05168466A (ja) 1993-07-02
IE832990L (en) 1984-06-20
GR78784B (es) 1984-10-02
EP0112184B1 (en) 1989-04-26
IL70441A0 (en) 1984-03-30
NZ206592A (en) 1987-02-20
EP0112184A3 (en) 1985-06-19
GB8333668D0 (en) 1984-01-25
PT77810A (en) 1984-01-01
ES528197A0 (es) 1985-05-01
RO87735B1 (ro) 1985-10-01
ZA839269B (en) 1985-07-31
JPS59118798A (ja) 1984-07-09
JPH0430400B2 (es) 1992-05-21
GB2132207A (en) 1984-07-04
EG16163A (en) 1989-01-30
AU2242683A (en) 1984-06-28
KR840007437A (ko) 1984-12-07
AU563466B2 (en) 1987-07-09
HU192971B (en) 1987-08-28
DD210709A1 (de) 1984-06-20
SU1194285A3 (ru) 1985-11-23
RO87735A2 (ro) 1985-10-31
IE56382B1 (en) 1991-07-17
EP0112184A2 (en) 1984-06-27
DE3379735D1 (en) 1989-06-01
DK578083D0 (da) 1983-12-15
CA1214413A (en) 1986-11-25
FI834594A (fi) 1984-06-21
DK578083A (da) 1984-06-21
IL70441A (en) 1986-11-30
JPH0771479B2 (ja) 1995-08-02
KR860001497B1 (ko) 1986-09-27
ES8504935A1 (es) 1985-05-01
FI834594A0 (fi) 1983-12-14

Similar Documents

Publication Publication Date Title
PT78777A (en) Process for preparing leucine derivatives and of pharmaceutical compositions containing the same
AU6655790A (en) New polypeptide compound and a process for preparation thereof
AU4869690A (en) Pyrazolopyridine compound and processes for preparation thereof
PH20198A (en) Antibiotic a51568 factor a and b,their method of preparation and pharmaceutical composition
AU584336B2 (en) New cephalosporins and processes for their preparation
IE811462L (en) Preparing tylactone.
EP0376609A3 (en) Antibiotic a80915 and process for its production
ES8406546A1 (es) Preparacion del nuevo complejo antibiotico cp-55358.
JPS5511541A (en) Novel antibiotics and their preparation
IL71407A (en) 9-deoxo-23-deoxy-9-o-forosaminyl-5-o-mycaminosyltylonolide antibiotics,their preparation and pharmaceutical and veterinary compositions containing them
BG95629A (en) Derivatives of 10, 11, 12, 13 - tetrahytdrodesmicozine, method for preparing them, and their use as pharmaceutical preparations
JPS56152478A (en) Optically active cephalosporin analog
ES2060962T3 (es) Antibioticos glicopeptidicos.